New South Wales Department of Health. (2006) National clinical guidelines for the management of drug use during pregnancy, birth and the early development years of the newborn. Sydney: New South Wales Department of Health.
| Preview | Title | Contact |
|---|---|---|
|
PDF
- Published Version
1MB |
These nationally agreed clinical guidelines are intended to support a range of health care workers who care for women with drug and alcohol use issues, and their infants and families. They have been developed through a process based on evidence reviews and expert consensus. The drugs covered include: opioids, alcohol, tobacco, cannabis, amphetamines, cocaine, benzodiazepines, inhalants.
Other topics covered are: breastfeeding, vertical transmission of blood-borne viruses, psychosocial aspects, obstetric implications, pain management in labour and early childhood development. Aboriginal and Torres Strait Islander issues are also addressed.
E Concepts in biomedical areas > Pregnancy
G Health and disease > Disease by cause (Aetiology) > Foetal, infant, newborn diseases (reproductive effects)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
N Communication, information and education > Recommendations > Practice / clinical guidelines
T Demographic characteristics > Pregnant woman
T Demographic characteristics > Affected family members / concerned persons
T Demographic characteristics > Child of person who uses substances
T Demographic characteristics > Mother
VA Geographic area > Australia and Oceania > Australia
Repository Staff Only: item control page